Ubrogepant | Abbvie | ||
50 and 100 mg ; Tablet |
Less Than $1000 mn
|
||
Less Than 5
|
Less Than 5
|
||
Less Than 5
|
Less Than 5
|
||
None | None | ||
UBRELVY is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults. | |||
Yes
|
Ubrelvy | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
********* | **** *** | **** *** | **** *** | **** *** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) |
***** ****** | **** *** | **** *** | **** *** | **** *** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) |
*** **** | **** *** | **** *** | **** *** | **** *** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) | **** ** *** **, **** (***** ****** *******) |
Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
---|---|---|---|---|---|
********* | *** \ ********* | *** **, **** | ******* | ********* ******** | ***** *** **** |
***** ****** | *** \ ********* | *** **, **** | ******* | **** | ***** *** **** |
*** **** | *** \ ********* | *** **, **** | ******* | **** | ***** *** **** |
Download ParaIV Report
Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
---|